13-cis-retinoic acid,Isotretinoin

13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.

Cross Reference

Introduction

To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 13-cis-retinoic acid,Isotretinoin?

13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin

MeSH term MeSH ID Detail
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Acne Vulgaris D000152 35 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Lung Neoplasms D008175 171 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with 13-cis-retinoic acid,Isotretinoin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 13-cis-retinoic acid,Isotretinoin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

What genes are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 13-cis-retinoic acid,Isotretinoin

Download all related citations
Per page 10 20 50 100 | Total 2952
Authors Title Published Journal PubMed Link
Sharquie KE et al. The therapeutic role of isotretinoin in the management of Behçet's disease: a single-blinded, controlled therapeutic study. 2013 J Drugs Dermatol pmid:23652909
Elpern DJ Isotretinoin and one patient's teary eyes: "please listen or I'll cry". 2013 Int. J. Dermatol. pmid:23679883
Stobaugh DJ et al. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System. 2013 J. Am. Acad. Dermatol. pmid:23683730
Ali FR and Al-Niaimi F Acne vulgaris. 2013 Br J Hosp Med (Lond) pmid:23656986
Dawson AL and Dellavalle RP Acne vulgaris. 2013 BMJ pmid:23657180
Moreno L et al. About the benefits of immunotherapy for high-risk neuroblastoma. 2013 J. Clin. Oncol. pmid:23295791
Stobaugh DJ et al. Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration Adverse Event Reporting System. 2013 Eur. J. Clin. Pharmacol. pmid:23052415
Alhusayen RO et al. Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study. 2013 J. Invest. Dermatol. pmid:23096714
Rademaker M Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us? 2013 Australas. J. Dermatol. pmid:23013115
Raza K et al. Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling. 2013 Mol. Pharm. pmid:23544848
Balakirski G et al. [Morbihan disease as a special form of rosacea: review of pathogenesis and new therapeutic options]. 2013 Hautarzt pmid:24201653
Baratli J and Megahed M [Lupoid perioral dermatitis as a special form of perioral dermatitis: review of pathogenesis and new therapeutic options]. 2013 Hautarzt pmid:24201654
McIntee TJ and Bruckner AL Challenges in optimizing isotretinoin use for acne vulgaris. 2013 JAMA Dermatol pmid:24172999
Blasiak RC et al. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris. 2013 JAMA Dermatol pmid:24173086
Petruzzi M et al. Topical retinoids in oral lichen planus treatment: an overview. 2013 Dermatology (Basel) pmid:23548887
Melnik BC and Schmitz G Are therapeutic effects of antiacne agents mediated by activation of FoxO1 and inhibition of mTORC1? 2013 Exp. Dermatol. pmid:23800068
BaÅŸak PY et al. The effects of systemic isotretinoin and antibiotic therapy on the microbial floras in patients with acne vulgaris. 2013 J Eur Acad Dermatol Venereol pmid:22239608
Cakir GA et al. Isotretinoin treatment in nodulocystic acne with and without polycystic ovary syndrome: efficacy and determinants of relapse. 2013 Int. J. Dermatol. pmid:22998438
Tankurt E et al. Esophageal ulcers: a possible adverse effect of isotretinoin. 2013 Turk J Gastroenterol pmid:24623299
Gan EY et al. Isotretinoin is safe and efficacious in Asians with acne vulgaris. 2013 J Dermatolog Treat pmid:22390469